1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Opsens Inc.
  6. News
  7. Press Releases
    OPS   CA6838231083

OPSENS INC.

(OPS)
  Report
Delayed Toronto Stock Exchange  -  05/20 04:00:00 pm EDT
1.930 CAD   +0.52%
05/19Opsens Presents Results of First-in-human Study of SavvyWire at European Conf
MT
05/19OPSENS SAVVYWIRE™ FIRST-IN-HUMAN RESULTS PRESENTED AT EUROPCR IN PARIS AND SIMULTANEOUSLY PUBLISHED IN EUROINTERVENTION JOURNAL
AQ
05/19Opsens Inc. Announces New Data Supporting the Safety and Efficacy of its SavvyWire Recently Approved by Health Canada for Transcatheter Aortic Valve Replacement Procedures
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société OPSENS INC.
05/19OPSENS SAVVYWIRE™ FIRST-IN-HUMAN RESULTS PRESENTED AT EUROPCR IN PARIS AND SIMULT..
AQ
05/18Opsens announces publication in jscai of data supporting the correlation between the op..
AQ
04/26Opsens announces health canada approval for its new tavr guidewire
AQ
04/13OPSENS : CEO Certification
PU
04/13OPSENS : CFO Certification
PU
04/13Opsens announces second quarter fiscal 2022 financial results
AQ
04/06Opsens to host second quarter fiscal year 2022 financial results conference call on wed..
AQ
03/14OpSens to Participate in the 32nd Annual Oppenheimer Healthcare Conference March 15th t..
AQ
02/25OpSens Reports on Voting Results from its Annual Shareholders Meeting
AQ
02/09Opsens appoints brad davis as new chief commercial officer
AQ
02/01Opsens announces abiomed 4-year supply agreement extension to 2028
AQ
01/28OPSENS : Corrected and Refiled Financial Statements 2021
PU
01/28OPSENS : Form 52-109f1r
PU
01/24Opsens named to 2022 otcqx best 50
AQ
01/13OPSENS : 52-109 F2 CEO Certification
PU
01/13OPSENS : 52-109 F2 CFO Certification
PU
01/13OpSens Announces FIRST Quarter fiscal 2022 Financial Results
AQ
01/06Opsens to host first quarter fiscal year 2022 financial results conference call on thur..
AQ
2021OPSENS : Annual Information Form
PU
2021OPSENS : Management information circular - English
PU
2021OPSENS : Notice of meeting - French
PU
2021OPSENS : Proxy
PU
2021OPSENS : Management Information Circular
PU
2021OPSENS : Annual Report 2021
PU
2021Opsens announces 510(k) submission to u.s. fda for new guidewire for the tavr procedure
AQ
2021OPSENS TO PRESENT AT THE LYTHAM PART : Presentation at 11 Am (ET), Monday December 13, 202..
AQ
2021OPSENS : Certification CEO
PU
2021OPSENS : Certification CFO
PU
2021OpSens Announces Fourth Quarter And Fiscal Year 2021 Financial Results
AQ
2021OpSens Successfully Completes 20-Patient in Human Clinical Study for TAVR Procedure
AQ
2021OpSens to Host Fourth Quarter Fiscal Year 2021 Financial Results Conference Call and Ye..
AQ
2021OpSens will Participate at Stifel 2021 Virtual Healthcare Conference and Canaccord Genu..
AQ
2021OPSENS' SAVVYWIRE™ Featured at the Transcatheter Cardiovascular Therapeutics 2021..
AQ
2021OPSENS : Successfully Treats First Patients in Human Clinical Study for TAVR Procedure
AQ
2021OPSENS : to Present at the Lytham Partners Fall 2021 Investor Conference
AQ
2021OPSENS : Receives Approval from Health Canada to Initiate First In-Man Clinical Study for ..
AQ
2021OPSENS : Appoints Lori Chmura to its Board of Directors
AQ
2021OPSENS : Announces Third Quarter Fiscal 2021 Record Financial Results
AQ
2021OPSENS : to Host Third Quarter Fiscal Year 2021 Financial Results Conference Call on Tuesd..
AQ
2021OPSENS : Receives Funding Support to Jointly Develop an Optical-Based Fuel Monitoring Syst..
AQ
2021OPSENS : will Participate and Present at two Investment Conferences - Lytham Partners and ..
AQ
2021OPSENS : to Participate in Virtual Fireside Chat at the 2021 RBC Capital Markets Global He..
AQ
2021OPSENS : Integrates its OptoWire's dPR and FFR Algorithms Within Cathmedical Cardiovascula..
AQ
2021OPSENS : Announces Second Quarter Fiscal 2021 Financial Results and Record FFR and dPR Rev..
AQ
2021OPSENS : Awarded Innovative Technology Contract by Vizient for OptoWire III
AQ
2021OPSENS : to Host Second Quarter Fiscal Year 2021 Financial Results Conference Call on Wedn..
AQ
2021OPSENS : to Present at Lytham Partners Spring 2021 Investor Conference
AQ
2021OPSENS : Announces Closing of $28.75 Million Bought Deal Public Offering Including $3.75 M..
AQ
2021OPSENS : Obtains CE Marking for the OptoWire III
AQ
2021OPSENS : Fiber Optic Sensing Technology Selected for the International Thermonuclear Exper..
AQ
2021OPSENS : Announces $25 Million Bought Deal Offering
AQ
2021OPSENS : Announces First Quarter Fiscal 2021 Financial Results
AQ
2021OPSENS : to Host First Quarter Fiscal Year 2021 Financial Results Conference Call on Wedne..
AQ
2020OPSENS : to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
AQ
2020OPSENS : Announces Fourth Quarter and Fiscal Year 2020 Financial Results
AQ
2020OPSENS : Recognized as One of the Fastest-Growing Company in North America on Deloitte's 2..
AQ
2020OPSENS : to Host Year-End Update Conference Call on Thursday, November 19, 2020
AQ
2020OPSENS : Awarded contract by major u.s. group purchasing organization
AQ
2020OPSENS : Awarded Contract by Major U.S. Group Purchasing Organization
AQ
2020OPSENS : to Present at Lytham Partners Virtual Investor Growth Conference
AQ
2020OPSENS : Announces Result for Q3 2020
AQ
2020OPSENS : 100,000 Cases Performed with the OptoWire
AQ
2020C-SUITE AT THE OPEN : Louis Laflamme, Chief Executive Officer, OpSens Inc., tells his Comp..
AQ
2020OPSENS : Announces Q2 2020 Results
AQ
2020OPSENS : continues to supply essential cardiovascular solutions to patients around the wor..
AQ
2020OPSENS : provides operational update - OpSens continues to supply essential cardiovascular..
AQ
2020OPSENS : Election Results for the Board of Directors
AQ
2020OPSENS : Receives FDA Approval of Optowire III
AQ
2020OPSENS : Announces Q1 2020 Results
AQ
2019OPSENS : Receives dPR Clearance from the FDA
AQ
2017OPSENS : Robin villeneuve appointed as chief financial officer
PU
2017OPSENS : REPORTS Q2 2017 RESULTS – QUARTERLY CONSOLIDATED REVENUES UP 75% TO $4.8 MI..
PU
Upcoming event on OPSENS INC.